Apex Biotechnology Corp (1733) — Working Capital to Net Assets Ratio
Apex Biotechnology Corp (1733) has a Working Capital to Net Assets ratio of 65.2% as of September 2025. Working capital of NT$1.18 Billion (current assets of NT$1.57 Billion minus current liabilities of NT$383.92 Million) is measured against net assets of NT$1.81 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Apex Biotechnology Corp (1733) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Apex Biotechnology Corp Working Capital to Net Assets (2009–2024)
This chart shows how Apex Biotechnology Corp's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2009 to 2024. As of September 2025, the ratio stands at 65.2%, reflecting working capital of NT$1.18 Billion against net assets of NT$1.81 Billion TWD. For the complete balance sheet picture, see 1733 total assets.
Annual Working Capital to Net Assets for Apex Biotechnology Corp (2009–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Apex Biotechnology Corp from 2009 to 2024, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check financial resilience of Apex Biotechnology Corp to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 63.9% | NT$1.17 Billion | NT$1.82 Billion | NT$1.64 Billion | NT$477.77 Million | ▲ +1.4 pp |
| 2023 | 62.5% | NT$1.12 Billion | NT$1.80 Billion | NT$1.51 Billion | NT$383.35 Million | ▲ +2.9 pp |
| 2022 | 59.6% | NT$1.08 Billion | NT$1.82 Billion | NT$1.65 Billion | NT$570.55 Million | ▲ +4.1 pp |
| 2021 | 55.5% | NT$973.97 Million | NT$1.75 Billion | NT$1.76 Billion | NT$785.89 Million | ▲ +6.9 pp |
| 2020 | 48.7% | NT$801.05 Million | NT$1.65 Billion | NT$1.68 Billion | NT$883.43 Million | ▼ -20.3 pp |
| 2019 | 69.0% | NT$1.16 Billion | NT$1.68 Billion | NT$1.78 Billion | NT$621.28 Million | ▲ +3.2 pp |
| 2018 | 65.7% | NT$1.08 Billion | NT$1.64 Billion | NT$1.58 Billion | NT$501.67 Million | ▲ +30.9 pp |
| 2017 | 34.9% | NT$580.26 Million | NT$1.66 Billion | NT$1.60 Billion | NT$1.02 Billion | ▼ -33.7 pp |
| 2016 | 68.6% | NT$1.19 Billion | NT$1.73 Billion | NT$1.60 Billion | NT$414.57 Million | ▲ +7.3 pp |
| 2015 | 61.3% | NT$1.18 Billion | NT$1.93 Billion | NT$1.58 Billion | NT$392.60 Million | ▲ +24.9 pp |
| 2014 | 36.4% | NT$679.72 Million | NT$1.87 Billion | NT$1.43 Billion | NT$752.29 Million | ▼ -19.0 pp |
| 2013 | 55.4% | NT$1.06 Billion | NT$1.92 Billion | NT$1.45 Billion | NT$383.35 Million | ▼ -18.4 pp |
| 2012 | 73.8% | NT$1.49 Billion | NT$2.01 Billion | NT$1.82 Billion | NT$332.53 Million | ▲ +7.3 pp |
| 2011 | 66.5% | NT$1.16 Billion | NT$1.75 Billion | NT$1.53 Billion | NT$368.30 Million | ▲ +2.7 pp |
| 2010 | 63.8% | NT$1.04 Billion | NT$1.63 Billion | NT$1.34 Billion | NT$302.11 Million | ▼ -2.2 pp |
| 2009 | 66.0% | NT$970.86 Million | NT$1.47 Billion | NT$1.26 Billion | NT$284.30 Million | — |